• Primidone (Mysoline): Mechanistic Precision for Translationa

  2026-04-21

  This article explores Primidone’s dual inhibition of TRPM3 and RIPK1, its selectivity over CYP19, and its translational relevance for neurodegenerative and gynecological disease models. We contextualize these mechanistic insights within the competitive antiepileptic drug landscape and provide actionable protocol guidance for researchers aiming to maximize translational impact while minimizing off-target endocrine risks.

• Alfuzosin HCl: Workflow Enhancements for BPH Research Assays

  2026-04-20

  Harness the precision of Alfuzosin HCl, a selective α1 adrenoceptor antagonist, to streamline lower urinary tract research and spectrophotometric quantification. This guide delivers actionable protocols, troubleshooting insights, and a data-driven translation of recent innovations for advanced benign prostatic hyperplasia (BPH) studies.

• Synthetic Lethality: Epigenetic Mcl-1 Targeting with BCL-XL

  2026-04-20

  This study demonstrates that epigenetic suppression of Mcl-1, combined with BCL-XL/BCL-2 inhibition, induces potent apoptosis in glioblastoma models. The findings underscore a synthetic lethal approach that overcomes apoptotic resistance, with significant translational potential for difficult-to-treat brain tumors.

• Alfuzosin HCl: Translational Mechanisms and Assay Precision

  2026-04-19

  Explore the advanced pharmacology and assay integration of Alfuzosin HCl, a selective α1 adrenoceptor antagonist, in benign prostatic hyperplasia research. This cornerstone article reveals translational mechanisms and evidence-based assay strategies distinct from prior reviews.

• Chlorpromazine HCl: Dopamine Receptor Antagonist in Cell Mod

  2026-04-18

  Chlorpromazine HCl combines robust dopamine receptor antagonism with unique utility as an endocytosis blocker, empowering both neuropharmacology and infection biology workflows. This article decodes key experimental strategies, protocol optimizations, and troubleshooting tips—anchored in the latest evidence—to help researchers leverage APExBIO’s high-purity reagent for reproducible, cross-domain insights.

• 10074-G5: Precision c-Myc Inhibition for Axis-Driven Cancer

  2026-04-17

  Explore how 10074-G5, a potent c-Myc inhibitor, enables advanced cancer research by selectively disrupting the c-Myc/TERT/NFκB axis. This article delivers actionable insights and novel perspectives for high-fidelity tumor regression and apoptosis studies.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Decoding Endotheli

  2026-04-16

  Explore the nuanced role of 5-(N,N-dimethyl)-Amiloride hydrochloride in dissecting endothelial injury and pH regulation. This article connects advanced mechanistic insights with practical assay strategies, offering unique depth beyond standard applications.

• Plant Exosome-like Nanovesicles Alleviate Testicular Injury

  2026-04-15

  This study reveals that exosome-like nanovesicles derived from Cistanche deserticola (CDELNs) mitigate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells via miRNA-mediated P21 inhibition. These findings highlight a novel intercellular regulatory pathway with relevance for male infertility research and therapeutic development.

• (S)-(+)-Ibuprofen: COX Inhibitor Workflows and Troubleshooti

  2026-04-14

  Harness (S)-(+)-Ibuprofen for high-precision COX inhibition in inflammation pathway research and pain mechanism studies. Discover stepwise protocols, advanced use-cases, and practical troubleshooting strategies that set APExBIO’s pharmaceutical-grade enantiomer apart in the field of nonsteroidal anti-inflammatory drug research.

• T-5224: Selective C-Fos/AP-1 Inhibitor for Arthritis Researc

  2026-04-13

  T-5224 (C-Fos/AP-1 inhibitor) is a highly selective small molecule targeting the AP-1 transcription factor complex, with validated efficacy in inflammatory and osteoclastogenic disease models. Its use enables precise modulation of MMPs and pro-inflammatory cytokines, advancing arthritis and neuroinflammation research. APExBIO supplies T-5224 as a research-grade tool for dissecting AP-1 mediated pathways.

• IWR-1-endo: Wnt Signaling Inhibitor Workflows & Best Practic

  2026-04-12

  Leverage IWR-1-endo for precise, reproducible inhibition of the Wnt/β-catenin signaling pathway in colorectal cancer and regenerative studies. This guide details actionable protocols, troubleshooting tips, and advanced workflow strategies validated by current research and APExBIO's robust product support.

• Wortmannin: PI3K Inhibitor Workflows for Cancer & Viral Rese

  2026-04-12

  Wortmannin’s unique status as a potent, selective, and irreversible PI3K inhibitor empowers precise dissection of cell signaling across oncology and virology. This article translates recent research breakthroughs and best practices into actionable protocols, workflow enhancements, and troubleshooting guidance for advanced users.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Proto

  2026-04-11

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) safeguards proteins during extraction by preventing degradation from endogenous proteases, without interfering with phosphorylation or cation-dependent assays. It is best used in workflows requiring protein integrity for downstream analyses such as Western blotting, co-immunoprecipitation, and kinase assays. Avoid use in workflows where DMSO or specific inhibitor components may interfere with target enzymes or detection chemistries.

• 2-NBDG: Precision Cellular Glucose Uptake in Metabolism Assa

  2026-04-11

  2-NBDG unlocks high-sensitivity, quantitative analysis of glucose uptake in live cells, enabling researchers to dissect metabolic changes in disease models with robust reproducibility. This article delivers advanced workflows, troubleshooting insights, and key innovations—bridging foundational research with practical assay optimization.

• 10074-G5: Small-Molecule c-Myc Inhibitor for Advanced Can...

  2026-04-10

  10074-G5 empowers cancer researchers to dissect and modulate the c-Myc signaling pathway with precision, making it a best-in-class tool for apoptosis, cell cycle arrest, and tumor regression studies. With robust experimental data, high purity, and versatile solubility, this APExBIO compound streamlines workflows across diverse cancer models and delivers reproducible results where transcription factor targeting is critical.

16254 records 1/1084 page Next 12345 下5页 Last page